Logo
Logo
高质量API。零中断。全球可靠性。
高质量API。零中断。全球可靠性。
Phone

Our Team at CPHI Frankfurt 2025

Deepak Sapra
Deepak Sapra

CEO, Pharmaceutical Services and Active Ingredients

Nirav Shah
Nirav Shah

Vice President, and Head, API - North Asia

Karun Gaur
Karun Gaur

Vice President And Head, Strategic Projects API

Dr. A Kalyan Chakravarthy
Dr. A Kalyan Chakravarthy

Executive VP & Head - SEAMEA & B2B Formulations

Kalpesh Modi
Kalpesh Modi

Vice President, and Head – EU Market, API & B2B Collaborations

E Sreedhar
E Sreedhar

Executive Vice President, API Regulatory Affairs

Gustavo Mayrink De Castro Marques
Gustavo Mayrink De Castro Marques

Vice President and Head, API Sales & Marketing, LATAM

Dr. NM Sekhar
Dr. NM Sekhar

Vice President, API R&D

R Lalitha Kumari
R Lalitha Kumari

Global Head of API Product Management & Head of Sales - US & Canada

关于 Dr. Reddy’s 原料药(API)业务

我们专注于为印度及海外的仿制药制剂生产商制造和供应多种原料药(API)。公司拥有超过 250 种活性药物成分 的多元化产品组合,广泛应用于胃肠道、心血管、糖尿病学、肿瘤、疼痛管理及皮肤科等主要治疗领域。 我们的原料药生产设施均符合 cGMP(ICH Q7) 标准,并定期接受国际监管机构的检查。目前我们拥有 8 家通过商业化检查的 USFDA 生产工厂,其中 6 家位于印度,墨西哥和英国各 1 家。

Dr. Reddy’s 的原料药业务覆盖多个全球市场,包括美国、拉丁美洲、欧洲、印度、俄罗斯以及其他独联体国家(CIS)。

  • 250+ 种原料药(APIs)

  • 8 个生产基地

  • 1970+ 份药物主文件(DMFs),覆盖全球市场

  • 325+ 项 ANDA(简略新药申请)

  • 全球累计申请 4500+ 项专利,其中 1125 项已获授权

  • 复杂原料药及制 剂方面具备丰富经验,支持早期市场准入

  • 成为80 多个国家制药公司的首选原料药供应商

可持续发展

可持续发展是我们使命的核心。在 2025 财年, 我们为 7.56 亿+ 患者 提供服务, 实现了 60% 的碳中, and drew 68% 的能源来自可再生能源,并自 2023 财年起持续保持水资源正效益(Water Positive)。

我们是唯一一家在 CDP(碳披露项目)中同时获得气候变化、水安全及供应商参与度 “A” 评级的印度制药公司,并入选 道琼斯可持续发展世界指数 及 标普全球可持续发展年鉴。

我们的目标

  • 2030 年实现 100% 可再生能源用电
  • 2030 年实现碳中和(范围 1 和范围 2)
  • 到 2030 年服务 15 亿名患者

我们以责任推动创新,以使命驱动规模化发展,以担当塑造更加健康的世界。.

我们的生产基地

Our plants

About CPHI Frankfurt 2025

This flagship global event brings together 2,400+ exhibitors, 62,000+ pharma professionals, and cutting-edge innovations across APIs, biopharma, contract services, packaging, machinery, and more. It’s where the world’s pharmaceutical leaders connect to unlock new opportunities, strengthen partnerships, and stay ahead in a rapidly shifting global market. As part of this vibrant ecosystem, we’re excited to engage with peers, customers, and collaborators. We're here to create lasting value and help you if you're exploring dependable API partnerships, looking to scale your sourcing strategies, or seeking operational agility. Let’s meet at CPHI Frankfurt. We’re ready to support your next phase of growth with reliable, agile, and future-ready API solutions.

Our Achievement (awards)

Tentative Approval for Generic Lumateperone capsules
calendar

Aug 05, 2025

Tentative Approval for Generic Lumateperone capsules

CDP Recognition
calendar

Jul 10, 2025

CDP Recognition

Dr. Reddys API team at CPHI China 2025
calendar

Jun 24, 2025

Dr. Reddys API team at CPHI China 2025

CPHI Japan 2025 - Exhibitor showcase session by Nirav K Shah, Vice President, Head API, North Asia
calendar

Apr 09, 2025

CPHI Japan 2025 - Exhibitor showcase session by Nirav K Shah, Vice President, Head API, North Asia

Dr. Reddys API team at CPHI Japan 2025
calendar

Apr 09, 2025

Dr. Reddys API team at CPHI Japan 2025

Dr. Reddys API team at DCAT 2025
calendar

Mar 17, 2025

Dr. Reddys API team at DCAT 2025

Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”
calendar

Feb 25, 2025

Dr. Reddy’s Wins Big at “Express Pharma Excellence Awards 2025”